What is Euro-Med Laboratories Philippines EV-to-Revenue?
EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Euro-Med Laboratories Philippines's enterprise value is ₱5,757 Mil.
Euro-Med Laboratories Philippines's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₱5,309 Mil. Therefore, Euro-Med Laboratories Philippines's EV-to-Revenue for today is 1.08.
The historical rank and industry rank for Euro-Med Laboratories Philippines's EV-to-Revenue or its related term are showing as below:
PHS:EURO'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.08 Med: 1.96 Max: 6.69
Current: 1.08
During the past 13 years, the highest EV-to-Revenue of Euro-Med Laboratories Philippines was 6.69. The lowest was 1.08. And the median was 1.96.
PHS:EURO's EV-to-Revenue is ranked better than 76.59% of 1021
companies
in the Drug Manufacturers industry
Industry Median: 2.29
vs PHS:EURO: 1.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Euro-Med Laboratories Philippines's EV-to-Revenue
For the Drug Manufacturers - Specialty & Generic subindustry, Euro-Med Laboratories Philippines's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Euro-Med Laboratories Philippines's EV-to-Revenue Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Euro-Med Laboratories Philippines's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Euro-Med Laboratories Philippines's EV-to-Revenue falls into.
Euro-Med Laboratories Philippines's current Enterprise Value is ₱5,757 Mil.
Euro-Med Laboratories Philippines's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱5,309 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines's share price for today is ₱0.75.
Euro-Med Laboratories Philippines's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₱1.28.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Euro-Med Laboratories Philippines EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Euro-Med Laboratories Philippines's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Euro-Med Laboratories Philippines (PHS:EURO) Business Description
Euro-Med Laboratories Philippines Inc is a pharmaceutical-based company that engages in the manufacture of pharmaceutical products such as large and small volume parenterals and other solutions. The company also manufactures sterile water for the injection, and other solutions such as ophthalmic, inhalation, irrigation and dialysis. It operates through the following segments: The Manufacturing pharmaceutical segment involves the manufacturing of pharmaceutical products. The Health and other care Service segment operates a dialysis center. Development and operation of quick-service restaurant segment include operations of the quick-service restaurant, catering, food production and other related services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PHS:EURO has been successfully added to your 